Matt Might
Matt Might | |
|---|---|
| Alma mater | |
| Spouse(s) | Cristina Casanova |
| Children | 3 |
| Scientific career | |
| Institutions | |
Matthew Might is the director of the Hugh Kaul Personalized Medicine Institute at the University of Alabama Birmingham.
Might received his bachelors in 2001 and PhD in 2007 from Georgia Tech, both in computer science. In 2008, he joined the faculty at the University of Utah, where he worked as a professor of computer science and pharmaceutical chemistry until 2017.[1] He was a visiting professor of biomedical informatics at Harvard Medical School.[2]
Might is a White House strategist for the Precision Medicine Initiative, and is an advisor for the Undiagnosed Diseases Network. In 2017, he was given a Rare Impact Award by the National Organization for Rare Disorders.[3] Might is the Chief Scientific Officer of the NGLY1 Foundation.[4]
Research[edit | edit source]
Might's early work focused on cybersecurity. In recent years, he has transitioned to personalized medicine and bioinformatics.[1]
Might wrote a blog post that went viral after his son, Bertrand, was diagnosed with NGLY1 deficiency, a rare disease that was previously unknown. This widespread publicity allowed him to locate several other patients and generate data on the characteristics of the disease.[5][6]
Might used an artificial intelligence system he was developing called mediKanren to find out that Bertrand had Pseudomonas, during a time when he was in critical condition.[7]
Personal life[edit | edit source]
Might is married to Cristina Casanova and has three children. His father was the president and CEO of Cable One, the cable-television division of the former Washington Post Company.[5] His wife is the daughter of Manuel Casanova.
References[edit | edit source]
- ↑ 1.0 1.1 "Matthew Might - Home - Faculty Profile - The University of Utah". faculty.utah.edu.
- ↑ Carter, Kendra. "UAB - School of Medicine - News - White House strategist to lead UAB's Personalized Medicine Institute". www.uab.edu.
- ↑ "Matthew Might, Ph.D. - 2017 Rare Impact Award Honoree - NORD (National Organization for Rare Disorders)". NORD (National Organization for Rare Disorders). 15 March 2017.
- ↑ "Staff". NGLY1. Retrieved 27 July 2019.
- ↑ 5.0 5.1 Mnookin, Seth (14 July 2014). "One of a Kind". The New Yorker.
- ↑ Longshore, Jane. "UAB - Medicine Magazine - Codebreaker: A deeply personal quest made Matthew Might a leader in precision medicine and brought him to UAB". www.uab.edu.
- ↑
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
